SAM-A PHARM. CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19,640 KRW | -4.20% |
|
-5.35% | +19.76% |
| Sales 2022 | 81.7B 59.8M | Sales 2023 | 97.21B 71.16M | Capitalization | 100B 73.27M |
|---|---|---|---|---|---|
| Net income 2022 | 11.91B 8.72M | Net income 2023 | 21.37B 15.65M | EV / Sales 2022 | 0.27 x |
| Net cash position 2022 | 79.24B 58M | Net cash position 2023 | 67.43B 49.36M | EV / Sales 2023 | 0.34 x |
| P/E ratio 2022 |
8.53
x | P/E ratio 2023 |
4.68
x | Employees | 295 |
| Yield 2022 |
2.4% | Yield 2023 |
4.57% | Free-Float | 30.23% |
More Fundamentals
* Assessed data
| 1 day | -4.20% | ||
| 1 week | -5.35% | ||
| Current month | -2.77% | ||
| 1 month | +22.75% | ||
| 3 months | +18.81% | ||
| 6 months | +15.87% | ||
| Current year | +19.76% |
1 week
19 380.00
20 900.00
1 month
15 860.0024 950.00
Current year
15 520.0024 950.00
1 year
15 220.0024 950.00
3 years
13 400.0027 100.00
5 years
9 770.0027 100.00
10 years
9 770.0035 850.00
| Managers | Title | Age | Since |
|---|---|---|---|
Mi-Ae Huh
CEO | Chief Executive Officer | 49 | 05-04-30 |
Jun Huh
CEO | Chief Executive Officer | 53 | 97-02-28 |
Young-Shik Gil
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jun Huh
CEO | Chief Executive Officer | 53 | 97-02-28 |
Mi-Ae Huh
CEO | Chief Executive Officer | 49 | 05-04-30 |
Yong-Seok Lee
BRD | Director/Board Member | 49 | 19-03-14 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-05 | 19,640 | -4.20% | 66,916 |
| 24-06-04 | 20,500 | +1.23% | 57,555 |
| 24-06-03 | 20,250 | +0.25% | 45,462 |
| 24-05-31 | 20,200 | -2.65% | 78,120 |
| 24-05-30 | 20,750 | -3.49% | 131,151 |
End-of-day quote Korea S.E., June 04, 2024
More quotes
Sam-A Pharm. Co., Ltd is a Korea-based company engaged in the manufacture and sale of pharmaceuticals. The Company's products include remedies for respiratory, antibiotics, dermatitis treatments, dyspeptic agents, cold remedies, antifebriles, antiphlogistics, analgesics, antihistamines, and remedies for the circulatory, gastrointestinal, urinary systems, cardiovascular and other general pharmaceuticals. It also provides children nutrition products under the brand name of NOMA.
Sector
Pharmaceuticals
Calendar
2024-08-12
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +19.76% | 87.8M | |
| +19.39% | 42.33B | |
| +21.25% | 22.47B | |
| +16.93% | 15.25B | |
| +19.83% | 14.29B | |
| +53.58% | 12.6B | |
| -0.05% | 6.79B | |
| -11.11% | 6.71B | |
| -8.87% | 5.73B | |
| +14.27% | 5.47B |
- Stock Market
- Equities
- A009300 Stock
